A blood clot removal method for removing blood clots from the vascular system of a patient, the blood clot removal method carried out on an implantable device in the patient's body and comprising: allowing a blood flow through a passageway between a first side wall and a second side wall, filtering blood clots with a filter provided in the blood flow passageway, and cleaning the filter with a cleaning device, wherein the cleaning device is moved from the first side wall towards the second side wall to move blood clots away from the blood flow passageway.

A device for regulating blood pressure in a heart chamber is provided. The device includes a shunt positionable within a septum of the heart. The shunt is designed for enabling blood flow between a loft heart chamber and a right heart chamber, wherein the flow rate capacity of the device is mostly a function of pressure in the left heart chamber.

The application relates to a hydrocephalus valve for draining CSF from the ventricle systems of patients. The valve has a housing with a housing interior and at least one first passage for admission and/or discharge. The valve has at least one body provided in the housing interior. The body is designed to move in at least one direction. At least one adjusting unit is provided. The application aims to improve tried-and-tested existing valves. To achieve this, the adjusting unit is designed to adjust at least one drainage rate in the passage, and to allow the drainage rate to be adjusted between 1 ml per hour and 1000 ml per hour at a pressure at the hydrocephalus valve of 20 cm water column, in order to slow or accelerate, by means of this adjustment, a change in pressure in the ventricle system that results from the drainage.

Filtering device for filtering cerebrospinal fluid are disclosed. An example filtering device may include a filter housing having an inlet for receiving cerebrospinal fluid from a patient and an outlet for returning filtered cerebrospinal fluid to the patient. The filter housing may include a plurality of layers coupled together and defining a fluid pathway therein between the inlet and the outlet. A filtering section may be defined within the filter housing along the fluid pathway. The filtering section may include a widened region of the fluid pathway that is configured to slow the passage of fluid therethrough.

The present disclosure provides tubing comprising porous fluoropolymers for use in non-medical and medical applications along with methods of making the tubing. Also described are medical devices including catheters and shunts comprising the tubing. Specifically, a catheter, cannula, drain, shunt, or totally implantable venous access port comprising a section of tubing with at least two lumens separated by septa, as well as an outer wall and a fluorinated liquid. Wherein the outer wall and the septa are a porous fluoropolymer and the fluorinated liquid is absorbed into the pores of both the septa and the outer wall of the tubing.

An intercostal-pump based fluid management system, as described herein, comprises an intercostal pump that is, generally, a resiliently flexible bulb having an inlet and an outlet. The inlet is attached to a first tube that extends from the intercostal pump to a first area of a patient's body, for example, the patient's pleural cavity. The outlet is connected to a second tube that extends from the intercostal pump to a second area of a patient's body, for example, the patient's peritoneal cavity. In use, the intercostal pump is placed between a first rib and a second rib in a patient. The intercostal pump operates by being successively compressed and decompressed between the first and second ribs as the patient breaths.

Drug delivery devices and methods are disclosed herein. In some embodiments, a drug can be delivered into a brain ventricle of a subject, where it can diffuse, flow, or otherwise travel across the ependyma and into the hippocampus. The drug can be delivered through a delivery device configured to selectively or transiently obstruct a portion of the ventricle, e.g., the temporal horn or a posterior portion of the temporal horn. The obstruction can define a partitioned volume of the ventricle, limiting or preventing flow of cerebrospinal fluid (CSF) into or out of the partitioned volume. Accordingly, a drug can be delivered into the partitioned volume without being diluted or carried away by CSF, allowing the drug to saturate the ependyma adjacent the hippocampus. The delivery device can allow a high concentration of drug to be achieved and/or maintained within the partitioned volume to enable maximal transependymal penetration to the hippocampus, while reducing the volume of drug needed to achieve a desired therapeutic effect and limiting delivery of the drug to non-targeted areas.

An implantable occlusion and tissue ingrowth resistant fluid interface is provided with a housing, an orifice and a catheter port. The housing is formed from at least one biocompatible material and is configured without sharp edges or corners. The housing at least partially defines an internal housing cavity. The orifice member at least partially defines an orifice between the internal housing cavity and an exterior of the housing. The orifice has an elongated transverse cross-section configured with a length that is at least four times its maximum width. The catheter port is located on the housing and is configured to couple with a catheter such that the internal housing cavity is in fluid communication with a lumen of the catheter when the catheter is coupled to the catheter port. Embodiments having a moving cylinder, a rotor, and non-chemical surface modifications, as well as methods of use are also disclosed.

A setting adjustment tool for a magnetically adjustable device implanted in a patient includes a circumference. A plurality of magnetic coils can be circumferentially distributed on a circumference of the tool. One of the magnetic coils can be movable along the circumference between a plurality of predetermined positions associated with the selectable performance settings. The magnetic coils may also be capable of attracting or repulsing the at least one magnet of the rotor of the implanted device in a radial direction by at least a predetermined angle within a plane of rotation of an at least one magnet of the rotor thereby inducing a rotating moment into the rotor.

The present disclosure provides a method and apparatus for draining. The apparatus includes a body, the body having a first compartment adjacent to a second compartment, the first compartment having an inlet port fluidly connected to an outlet port, the inlet port defining a needle seat within the first compartment, a first rod hole for operation with a second rod hole in the second compartment, and a plurality of venting holes, the second compartment having a plurality of spaced notches along. The apparatus further includes a setting rod, the setting rod having a shaft and a sealing head, the shaft sized to be slideably maintained in the first rod hole and the second rod hole, the sealing head slideably attached to an end of the shaft and sized to obstruct fluid flow from the inlet port at the needle seat.